Overview Fundamentals API Earnings EOD API Sample Code Pricing

Adial Pharmaceuticals Inc (ADIL NASDAQ) stock market data APIs

$1.09 -0.04(-3.5%) as of July 12, 2024
Price chart is built with Anychart

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Adial Pharmaceuticals Inc Financial Data Overview

4 784 K
4 233 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ADIL',
Type: 'Common Stock',
Name: 'Adial Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00HNGDTR4',
CIK: '1513525',
EmployerIdNumber: '82-3074668',
FiscalYearEnd: 'December',
IPODate: '2018-07-30',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic Primary',
IsDelisted: false,

Adial Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -6 463 630
  • Earnings Per Share -4.98
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Adial Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.33

Get Adial Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?